THE EVIDENCE FOR 20 MG A DAY OF FLUOXETINE AS THE OPTIMAL DOSE IN THE TREATMENT OF DEPRESSION

被引：92

作者：

ALTAMURA, AC

MONTGOMERY, SA

WERNICKE, JF

机构：

[1] ST MARYS HOSP, SCH MED, DEPT PSYCHIAT, LONDON W2 1NY, ENGLAND

[2] ELI LILLY & CO, INDIANAPOLIS, IN 46285 USA

来源：

BRITISH JOURNAL OF PSYCHIATRY | 1988年 / 153卷

关键词：

D O I：

10.1192/S0007125000297377

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：109 / 112

页数：4

共 10 条

[1]

DORNSEIF BE, 1988, 1988 NEW CLIN DRUG E

[2]

FABRE LF, 1987, J CLIN PSYCHIAT, V48, P406

[3]

FEIGHNER JP, 1985, J CLIN PSYCHIAT, V46, P20

[4] A DOUBLE-BLIND COMPARISON OF ZIMELIDINE AND AMITRIPTYLINE IN ENDOGENOUS-DEPRESSION [J].

MONTGOMERY, SA ;

MCAULEY, R ;

RANI, SJ ;

ROY, D ;

MONTGOMERY, DB .

ACTA PSYCHIATRICA SCANDINAVICA, 1981, 63 :314-327

[5]

MONTGOMERY SA, 1986, 15TH CINP C

[6]

STARK P, 1985, J CLIN PSYCHIAT, V46, P7

[7] 5-HT REUPTAKE INHIBITORS PLUS TRYPTOPHAN IN ENDOGENOUS-DEPRESSION [J].

WALINDER, J ;

CARLSSON, A ;

PERSSON, R .

ACTA PSYCHIATRICA SCANDINAVICA, 1981, 63 :179-190

[8]

WERNICKE JF, 1988, PSYCHOPHARMACOL BULL, V24, P183

[9]

WERNICKE JF, 1987, PSYCHOPHARMACOL BULL, V23, P164

[10]

WOOD KM, 1982, BRIT J CLIN PRACTI S, V19, P42

← 1 →